Abeona Therapeutics (ABEO) Short Interest Ratio & Short Volume → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free ABEO Stock Alerts $3.91 -0.23 (-5.56%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Abeona Therapeutics Short Interest DataCurrent Short Volume2,060,000 sharesPrevious Short Volume1,990,000 sharesChange Vs. Previous Month+3.52%Dollar Volume Sold Short$15.74 millionShort Interest Ratio / Days to Cover4.3Last Record DateApril 15, 2024Outstanding Shares27,350,000 sharesFloat Size25,910,000 sharesShort Percent of Float7.95%Today's Trading Volume1,219,226 sharesAverage Trading Volume492,081 sharesToday's Volume Vs. Average248% Short Selling Abeona Therapeutics ? Sign up to receive the latest short interest report for Abeona Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABEO Short Interest Over TimeABEO Days to Cover Over TimeABEO Percentage of Float Shorted Over Time Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Abeona Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,060,000 shares $15.74 million +3.5%8.0%4.3 $7.64 3/31/20241,990,000 shares $14.43 million +17.1%7.7%6 $7.25 3/15/20241,700,000 shares $14.67 million +3.7%6.6%4.8 $8.63 2/29/20241,640,000 shares $11.32 million +5.1%7.0%5.4 $6.90 2/15/20241,560,000 shares $10.12 million +100.4%6.7%5.4 $6.49 1/31/2024778,500 shares $3.17 million +17.6%3.3%3.5 $4.07 Get the Latest News and Ratings for ABEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024662,100 shares $3.48 million +9.6%2.8%3.6 $5.25 12/31/2023603,900 shares $3.03 million +40.7%2.6%3.4 $5.01 12/15/2023429,200 shares $2.09 million -21.8%1.8%2.5 $4.87 11/30/2023549,000 shares $2.64 million -9.1%2.4%3.8 $4.80 11/15/2023603,700 shares $2.51 million -4.2%2.6%5.6 $4.15 10/31/2023630,400 shares $2.41 million +1.9%2.8%5.6 $3.82 10/15/2023618,500 shares $2.56 million 0.0%2.8%4.9 $4.14 9/30/2023618,700 shares $2.60 million +2.9%2.8%4.5 $4.21 9/15/2023601,400 shares $2.42 million +20.2%2.7%4.3 $4.03 8/31/2023500,500 shares $2.22 million +13.2%2.2%3 $4.43 8/15/2023442,000 shares $1.52 million -17.8%1.9%2.4 $3.45 7/31/2023538,000 shares $1.84 million -27.5%2.6%3.1 $3.42 7/15/2023742,500 shares $2.88 million +38.6%3.6%4.4 $3.88 6/30/2023535,900 shares $2.16 million +13.7%2.6%3.3 $4.03 6/15/2023471,400 shares $2.12 million +8.5%2.7%3 $4.49 5/31/2023434,500 shares $1.34 million +18.5%2.4%3 $3.09 5/15/2023366,600 shares $1.13 million -28.4%2.0%2.6 $3.08 4/30/2023512,300 shares $1.57 million -14.8%3.0%3.5 $3.07 4/15/2023601,000 shares $1.68 million -19.9%3.5%3.8 $2.79 3/31/2023750,500 shares $2.12 million +24.2%4.4%4.1 $2.82 3/15/2023604,400 shares $1.58 million +31.3%3.6%2.6 $2.62 2/28/2023460,500 shares $1.05 million +6.7%2.8%1.9 $2.29 2/15/2023431,600 shares $1.03 million -17.7%2.6%1.8 $2.38 1/31/2023524,300 shares $1.32 million -28.2%3.2%1.7 $2.52 1/15/2023730,200 shares $1.94 million -29.1%4.4%1.8 $2.65 12/30/20221,030,000 shares $3.17 million -4.6%6.2%2 $3.08 12/15/20221,080,000 shares $3.08 million +4.9%6.5%2.1 $2.85 11/30/20221,030,000 shares $3.87 million -3.7%6.2%2.1 $3.76 11/15/20221,070,000 shares $4.32 million +47.7%6.6%2.3 $4.04 10/31/2022724,600 shares $3.33 million +19.3%14.7%1.6 $4.59 10/15/2022607,300 shares $2.61 million +138.5%12.3%1.6 $4.30 9/30/2022254,600 shares $773,984.00 +43.4%5.2%0.9 $3.04 9/15/2022177,500 shares $722,425.00 -9.0%3.3%1 $4.07 8/31/2022195,100 shares $710,164.00 -25.8%3.6%1.1 $3.64#1 election stock (Ad)I’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. For the full story, click here. ABEO Short Interest - Frequently Asked Questions What is Abeona Therapeutics' current short interest? Short interest is the volume of Abeona Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,060,000 shares of ABEO short. 7.95% of Abeona Therapeutics' shares are currently sold short. Learn More on Abeona Therapeutics' current short interest. What is a good short interest ratio for Abeona Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABEO shares currently have a short interest ratio of 4.0. Learn More on Abeona Therapeutics's short interest ratio. Which institutional investors are shorting Abeona Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abeona Therapeutics: Concourse Financial Group Securities Inc., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Abeona Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.95% of Abeona Therapeutics' floating shares are currently sold short. Is Abeona Therapeutics' short interest increasing or decreasing? Abeona Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,060,000 shares, an increase of 3.5% from the previous total of 1,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Abeona Therapeutics' float size? Abeona Therapeutics currently has issued a total of 27,350,000 shares. Some of Abeona Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abeona Therapeutics currently has a public float of 25,910,000 shares. How does Abeona Therapeutics' short interest compare to its competitors? 7.95% of Abeona Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Abeona Therapeutics: Immunic, Inc. (3.20%), Repare Therapeutics Inc. (2.13%), GlycoMimetics, Inc. (4.67%), CytomX Therapeutics, Inc. (5.30%), Societal CDMO, Inc. (0.00%), Relmada Therapeutics, Inc. (5.67%), Nuvectis Pharma, Inc. (11.84%), Citius Pharmaceuticals, Inc. (8.29%), Rezolute, Inc. (0.60%), Cartesian Therapeutics, Inc. (45.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Abeona Therapeutics stock? Short selling ABEO is an investing strategy that aims to generate trading profit from Abeona Therapeutics as its price is falling. ABEO shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abeona Therapeutics? A short squeeze for Abeona Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABEO, which in turn drives the price of the stock up even further. How often is Abeona Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABEO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Immunic Short Interest Repare Therapeutics Short Interest GlycoMimetics Short Interest CytomX Therapeutics Short Interest Societal CDMO Short Interest Relmada Therapeutics Short Interest Nuvectis Pharma Short Interest Citius Pharmaceuticals Short Interest Rezolute Short Interest Cartesian Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABEO) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing